| P2093 | author name string | Hoe Suk Kim | |
| | Lianji Tian | |
| | Woo Kyung Moon | |
| | Hyeonjin Kim | |
| | Sul Ki Choi | |
| | Yujin Sun | |
| | Minji Jung | |
| P2860 | cites work | Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer. | Q55230988 |
| | Autophagy in Multiple Myeloma: What Makes You Stronger Can Also Kill You | Q60188463 |
| | Tamoxifen in the treatment of breast cancer | Q77598704 |
| | Macroautophagy signaling and regulation | Q37608022 |
| | The multiple roles of autophagy in cancer | Q37840892 |
| | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 |
| | The role of autophagy in cancer: therapeutic implications | Q37924056 |
| | Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors | Q39337473 |
| | Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling | Q39783619 |
| | Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance | Q39883237 |
| | A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance | Q39940036 |
| | Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. | Q40174892 |
| | Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance | Q40253550 |
| | RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation | Q40344986 |
| | Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. | Q40635044 |
| | The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway | Q40789651 |
| | Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments | Q40895734 |
| | Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. | Q42812911 |
| | Ras is involved in the negative control of autophagy through the class I PI3-kinase | Q42830028 |
| | Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. | Q44653812 |
| | Increased choline kinase activity and elevated phosphocholine levels in human colon cancer | Q22009964 |
| | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance | Q24645668 |
| | Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy | Q27024127 |
| | Mechanisms of disseminated cancer cell dormancy: an awakening field | Q27027015 |
| | Oncogenic kinase signalling | Q28189493 |
| | Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K | Q28200766 |
| | Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers | Q28217662 |
| | Structure and function of choline kinase isoforms in mammalian cells | Q28248624 |
| | Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells | Q28259789 |
| | Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression | Q28282754 |
| | Cancer drug resistance: an evolving paradigm | Q29616694 |
| | Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis | Q29617725 |
| | Pancreatic cancers require autophagy for tumor growth | Q29620331 |
| | Pathways to tamoxifen resistance | Q30441001 |
| | Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals | Q30665733 |
| | Molecular causes of the aberrant choline phospholipid metabolism in breast cancer | Q30939042 |
| | Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase | Q33796255 |
| | The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. | Q33959529 |
| | Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy | Q34135239 |
| | Ki67 protein: the immaculate deception? | Q34570709 |
| | Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells | Q35046962 |
| | eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. | Q35534450 |
| | Choline phospholipid metabolism: a target in cancer cells? | Q35549481 |
| | Autophagy as a cell death and tumor suppressor mechanism | Q35743138 |
| | Models, mechanisms and clinical evidence for cancer dormancy | Q36844303 |
| | Deconvoluting the context-dependent role for autophagy in cancer | Q36876716 |
| | The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells | Q36972761 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| | tamoxifen | Q412178 |
| P304 | page(s) | e0141110 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells | |
| P478 | volume | 10 | |